Market Newsdesk

SRAX Announces Sequire Platform Has Over 3 Million Retail Investors

LOS ANGELES–(BUSINESS WIRE)–
SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced that Sequire has grown to over 3 million retail investors.

“We have been discussing the importance of retail investors in public companies since the inception of Sequire. It’s the very reason why we built the platform and related tools — to help companies effectively communicate with these investors. The current environment in the capital markets is only validating what we have been preaching for years,” said Christopher Miglino, Founder and CEO of SRAX. “Through our LD Micro conferences and our virtual event partners, we are helping educate investors and providing them with tools that will help them be more successful.”

The Sequire platform is an operating system for publicly traded companies that through the use of machine learning helps companies identify prospective retail investors. The platform is also creating a community of retail investors with interests in specific sectors. These investors are participating in education and virtual events. Sequire has aspirations to be used by every publicly traded company.

About SRAX

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.

Cautionary Statement Regarding Forward-Looking Information:

This news release contains “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in our business, and our need for future capital. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in SRAX’s periodic reports filed with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2019, its Quarterly Reports on Form 10-Q as well as in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005454/en/

Bri Kelvin

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Venture Capital Software Networks Finance Banking Data Management Professional Services Technology

MEDIA:

Logo

Phreesia Named 2021 Best in KLAS for Patient Intake Management

RALEIGH, N.C.–(BUSINESS WIRE)–
Phreesia today announced it has been named 2021 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2021 Best in KLAS: Software and Services,” KLAS recognized the industry’s top-performing healthcare IT and services companies, based on feedback from healthcare organizations.

“Each year, thousands of healthcare professionals across the globe take the time to share their voice with KLAS,” said KLAS President Adam Gale. “Vendors who win the title of “Best in KLAS” should celebrate and remember that providers now accept only the best from their products and services. The Best in KLAS award serves as a signal to provider and payer organizations that they should expect excellence from the winning vendors.”

The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations.

Phreesia earned an overall top score of 91.3, based on provider feedback across a range of customer experience pillars, including culture, loyalty, operations, product, relationship and value.

This year’s award marks the third consecutive year that Phreesia has been recognized as the top-rated patient intake management vendor by KLAS. Phreesia garnered Best in KLAS honors in 2020 and was named Category Leader in 2019 after KLAS launched the new category the previous year.

“We’re honored to receive this award, especially given that our top ranking was determined by the first-hand perspectives of healthcare organizations,” said Phreesia CEO Chaim Indig. “This wouldn’t have been possible without the support from our clients and our team members, and we’re grateful to be regarded as a leader in this valuable part of the care continuum.”

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a safe, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005301/en/

Annie Harris

[email protected]

929-526-2611

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Data Management Health Technology Practice Management Software General Health

MEDIA:

Logo

NextGen Healthcare Enables CHC to Provide Whole Person Care Including Behavioral Health Services and Virtual Visits

Platform Allows Philadelphia-based Clinics to Safely Treat Broad Array of Physical and Mental Health Needs During Pandemic

ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, announced that its client Delaware Valley Community Health (DVCH) is leveraging NextGen® Behavioral Health Suite and NextGen Virtual Visits™ to deliver whole person care for underserved patients. DVCH operates eight Federally Qualified Health Centers (FQHCs) in Southeastern Pennsylvania.

As a longtime user of NextGen Enterprise EHR, DVCH clinics began utilizing NextGen Behavioral Health Suite to provide coordinated care among specialists within its network during the COVID-19 pandemic. This platform enables seamless handoffs among providers, enabling patients to be treated for physical ailments as well as mental health conditions that may be discovered during the visit. The majority of the clinics’ behavioral health visits originate with a medical visit, which highlights the importance of offering whole person care. Since the onset of the health crisis last year, DVCH has seen a 36 percent increase in behavioral health visits over the same period the prior year and more than 60 percent of DVCH’s patient visits are now delivered via telehealth.

“With NextGen Virtual Visits, our providers can continue treating patients throughout the pandemic and using the NextGen Behavioral Health Suite enables us to easily refer patients to mental health specialists within our clinics,” said Isaiah Nathaniel, chief information officer, DVCH. “The integrated platform allows us to reach more patients and provide potentially life-saving mental health counsel.”

“The rising need for mental health services underscores the importance of offering an integrated, whole person approach to care that is accessible and safe for all,” said John Beck, chief solutions officer, NextGen Healthcare. “We are pleased to see that NextGen Virtual Visits are especially useful for behavioral health services where patients appreciate the convenience and increased access to their providers.”

According to a recent article on the JAMA Network, the prevalence of depression symptoms has increased more than threefold, from 8.5 percent before COVID-19 to 27.8 percent during COVID-19, compared with the most recent population-based estimates of mental health in the U.S.

NextGen Healthcare partners with complex multi-disciplinary organizations to solve their whole person care strategy. Click here to learn how Delaware Valley Community Health built a pathway to success during the pandemic.

About Delaware Valley Community Health Center

Delaware Valley Community Health, Inc. (DVCH) is a private, nonprofit healthcare organization that operates eight Federally Qualified Health Centers (FQHCs) in Southeastern Pennsylvania. DVCH delivers high quality, community based, Primary Medical, Dental and Behavioral Health Services to patients, regardless of their ability to pay at the time of service. For over 50 years, DVCH has been the safety net provider for Latino and African-American communities. Learn more at https://dvch.org/.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005295/en/

Media Contact

Tami Stegmaier

NextGen Healthcare, Inc.

(949) 237-6083

[email protected]

KEYWORDS: United States North America Pennsylvania Georgia

INDUSTRY KEYWORDS: Practice Management Managed Care Other Health Health General Health Women Men Mental Health Family Hospitals Consumer

MEDIA:

Logo

Pioneer Power Awarded Additional Locations by Large Home Improvement Retailer

30% Increase in Locations After One Month Demonstrates Focus on Sustainable Power

FORT LEE, N.J.–(BUSINESS WIRE)–
Pioneer Power Solutions, Inc. (Nasdaq: PPSI) (“Pioneer Power” or the “Company”), a company engaged in the manufacture, sale and service of electrical transmission, distribution and on-site power generation equipment, today announced that it has been awarded an additional group of locations by one of the largest home improvement retailers in the U.S. as part of the previously announced service contract for preventative maintenance and repairs at the retailer’s stores.

The award represents a 30% expansion of the contract. Pioneer will provide scheduled generator preventative maintenance and emergency repair services for the retailer’s engine generator equipment assets. The aforementioned contract is expected to begin in March, 2021.

Nathan Mazurek, Pioneer’s Chairman and Chief Executive Officer, said, “In less than a month since the initial contract award, the retailer has seen the benefits of our offering, as well as the value of sustainable backup power at their locations. We have demonstrated the ability of our expert technicians to provide maintenance and repair services across a broad range of engine manufacturers and models. We continue to believe there are additional expansion opportunities for us with this retailer, and this expansion further bolsters our outlook and backlog for the year.”

About Pioneer Power Solutions, Inc.

Pioneer Power Solutions, Inc. manufactures, sells and services a broad range of specialty electrical transmission, distribution and on-site power generation equipment for applications in the utility, industrial, commercial and backup power markets. The Company’s principal products include switchgear and engine-generator controls, complemented by a national field-service network to maintain and repair power generation assets. To learn more about Pioneer, please visit its website at www.pioneerpowersolutions.com.

Safe Harbor Statement:

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the Company’s ability to successfully increase its revenue and profit in the future, (ii) general economic conditions and their effect on demand for electrical equipment, (iii) the effects of fluctuations in the Company’s operating results, (iv) the fact that many of the Company’s competitors are better established and have significantly greater resources than the Company, (v) the Company’s dependence on a single customer for a large portion of its business, (vi) the potential loss or departure of key personnel, (vii) unanticipated increases in raw material prices or disruptions in supply, (viii) the Company’s ability to realize revenue reported in the Company’s backlog, (ix) future labor disputes, (x) changes in government regulations, (xi) the fact that the Company’s chairman, who controls a majority of the Company’s voting power, may develop interests that diverge from yours, (xii) the liquidity and trading volume of the Company’s common stock and (xiii) an outbreak of disease, epidemic or pandemic, such as the global coronavirus pandemic, or fear of such an event.

More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual and Quarterly Reports on Form 10-K and Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005150/en/

Brett Maas, Managing Partner

Hayden IR

(646) 536-7331

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Other Energy Manufacturing Energy Construction & Property Building Systems Other Manufacturing

MEDIA:

Posted on February 2, 2021 8:03 am

Renesas Simplifies 5G Networks with Industry’s First IEEE 1588 Synchronization Software in Clear Source Code Format

Renesas Simplifies 5G Networks with Industry’s First IEEE 1588 Synchronization Software in Clear Source Code Format

IEEE 1588 Software Combined with Renesas’ Leading Timing Silicon for a Comprehensive Timing Solution with Increased Flexibility and Excellent Packet Delay Variation

TOKYO–(BUSINESS WIRE)–
Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today introduced PTP (Precision Time Protocol) Clock Manager, the industry’s first Linux-based clock management software, providing an easy-to-use and accessible timing synchronization solution for telecom networks, including 4G, 5G, and open radio access network (O-RAN), including both fronthaul and backhaul systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210202005345/en/

Industry’s first clear source PTP clock manager software for Linux (Graphic: Business Wire)

The new IEEE 1588 Renesas PTP Clock Manager includes APIs to connect Renesas timing ICs with any network processor via the Linux standard PTP stack, offering broad access to PTP synchronization without the need for time-intensive customization. This time stamp unit (TSU)-agnostic approach provides customers access to their processor/clock combination of choice and eliminates the need to create their own APIs, allowing them greater design flexibility while reducing development costs. When used with Renesas clock solutions, the PTP Clock Manager is provided under a “no fees” license.

“Timing precision becomes more critical as carriers migrate to 5G networks. The open-source Linux environment offers the flexibility to create IEEE 1588-aware systems with a TSU and clock combination of choice for optimum timing performance,” said Bobby Matinpour, Vice President, Data Center Business Division at Renesas. “Providing PTP synchronization alongside a suite of best-in-class timing solutions without license fees reshapes the network system development landscape. We are excited to continue driving innovation that fosters and enables new vendors to succeed, consistent with initiatives like O-RAN.”

“We are collaborating closely with Renesas to develop joint reference designs that help to simplify and accelerate the time to market for our customers,” said Gilles Garcia, Senior Director of Marketing, Wired and Wireless Group, Xilinx, Inc. “5G networks demand high accuracy 1588 PTP for time and phase synchronization. Renesas’ PTP Clock Manager is an important enabler for our Versal AI Core Series VCK190 and Zynq UltraScale+ RFSoC ZCU216 evaluation kits, along with Xilinx Ethernet Solutions.”

The new Linux-based PTP Clock Manager also works with Renesas’ ClockMatrix™ 8A3400x family of high-performance, precision, multi-channel timing devices and IEEE 1588-compliant 82P339xx devices to simplify the integration of telecom PTP solutions.

Key Features of the PTP Clock Manager

• Extremely effective packet delay variation (PDV) filter for IEEE 1588 networks
• Linux kernel PHC subsystem supports Renesas ClockMatrix timing devices
• Backwards compatibility with Linux v3.0 or later
• Reduces the impact of packet-delayed variations caused by random queuing delays
• Enables worldwide compliance with ITU-T synchronization recommendations
• Available as clear source code to simplify debugging

As the market leader in silicon timing, Renesas offers the only “one-stop-shop” for timing solutions, offering expertise and products from full-featured system solutions to simple clock building-block devices. The new PTP clock manager extends this comprehensive portfolio to include both silicon and software solutions to support a full range of clocking needs.

Availability

The Linux-based PTP Clock Manager is available now free of charge under license. For more information, please visit renesas.com/clockmanager.

About Renesas Electronics Corporation

Renesas Electronics Corporation (TSE: 6723) delivers trusted embedded design innovation with complete semiconductor solutions that enable billions of connected, intelligent devices to enhance the way people work and live. A global leader in microcontrollers, analog, power, and SoC products, Renesas provides comprehensive solutions for a broad range of automotive, industrial, Infrastructure, and IoT applications that help shape a limitless future. Learn more at renesas.com. Follow us on LinkedIn, Facebook, Twitter, and YouTube.

(Remarks). ClockMatrix is a trademark of Renesas Electronics Corporation. All other names of products or services mentioned in this press release are trademarks or registered trademarks of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005345/en/

Americas

Don Parkman

Renesas Electronics Corporation

+ 1-408-887-4308

[email protected]

KEYWORDS: United States Japan North America Asia Pacific California

INDUSTRY KEYWORDS: Software Technology Hardware Semiconductor

MEDIA:

Logo

Photo

Industry’s first clear source PTP clock manager software for Linux (Graphic: Business Wire)

Ulta Beauty Announces Diversity and Inclusion Commitments

Rooted in Intent, Influence and Impact, Commitments Champion Diversity in Retail and Beauty

BOLINGBROOK, Ill.–(BUSINESS WIRE)–
Ulta Beauty, the nation’s largest beauty retailer, today shared diversity and inclusion commitments with a keen focus on brand amplification and support, assortment growth, and equitable, welcoming guest and associate experiences. The 2021 commitments reflect a planned investment of more than $25 million. Additionally, the company announced Tracee Ellis Ross, CEO and founder, PATTERN Beauty, as the company’s Diversity and Inclusion Advisor, a formalized role to provide counsel, inspiration and drive accountability.

“As the country’s beauty retail leader, we believe we have the power to shape how the world sees beauty and as such, we have a responsibility to inspire positive change and drive greater diversity, inclusivity and equity,” said Mary Dillon, CEO, Ulta Beauty “We are deeply committed to leading purposefully with and for underrepresented voices across retail and beauty on our D&I journey.”

Ulta Beauty has long prioritized diversity and inclusion within its’ overarching business strategy, as reflected in its mission: everyday, we use the power of beauty to bring to life the possibilities that lie within each of us. The 2021 commitments provide a holistic view of tangible efforts intended to further existing work to champion diversity and ultimately, to ensure guests, associates, partners and communities feel connected to and reflected at Ulta Beauty.

“I look forward to formalizing an already existing dialogue and partnership around diversity and inclusion with Mary Dillon and the Ulta Beauty team,” said Tracee Ellis Ross. “This work requires commitment and accountability from Ulta Beauty to ensure measurable goals are achieved. I am hopeful and optimistic our work together will create foundational change.”

Commitment to Amplifying & Investing in Underrepresented Voices

Recognizing the undeniable opportunity to consistently celebrate and support the influence underrepresented brands and voices have on the beauty industry, Ulta Beauty will dedicate time, space and resources to these important leaders.

• Approximately $20 million will be allocated to media investments across endemic and multi-cultural platforms to create more personal connections with LatinX, Black and other communities, more than doubling the spend of the last three years.
• Ulta Beauty proudly debuted MUSE: Magnify, Uplift, Support, Empower, a platform to celebrate, honor, and amplify Black voices in beauty. The campaign shines a light on bold, brilliant and beautiful Black women who have defied and defined limits with marquee placements on The Today Show, Good Morning America and This is Us.

Commitment to Black-Owned Brands

As Ulta Beauty’s unparalleled assortment continues to evolve, the company will work directly with Black founders and entrepreneurs with the goal to grow brands so these beauty leaders can thrive as they continue to serve the Black community.

• To increase the presence of Black entrepreneurs, Ulta Beauty will double the number of Black-owned brands in its assortment by the end of 2021.
• More than $4 million will be dedicated to marketing support of Black-owned brands within the company’s assortment to fuel brand awareness and sustain growth.

Commitment to Guest Experiences

Everything is in service of guest experiences and as such, Ulta Beauty remains fervently committed to creating exciting, welcoming and equal experiences for every guest who visits the retailer.

• Introducing quarterly, in-store training for all store and salon associates in March 2021 to reinforce inclusivity and address unconscious bias. These mandatory trainings account for a $2 million investment and are additional to Ulta Beauty’s existing store and salon trainings.
• Building upon Race Matters Leadership Training which debuted in 2020, the company will implement a mandatory 2.0 version across field, distribution center and corporate associates in 2021.

Commitment to Associate Experiences

Ulta Beauty understands the importance of fostering an inclusive, bias-free and equitable workplace to enable all associates to reach their full potential. The company will continue to prioritize leading as a diversity-forward employer, further strengthening its diverse workforce with investments to advance associate competencies and foster even greater collaboration.

• More than doubled D&I trainings across the enterprise for 2021 for the second year in a row.
• Launched inclusive recruiting efforts with a diverse slate mandate.
• Established a Diverse Leaders Program to empower more than 30, high-potential associates as future company leaders with CEO and executive mentorship.
• Annual performance reviews include evaluation against the core value of Champion Diversity and the key competency of Inclusion.

“Authenticity as an inclusive brand with welcoming experiences for all and an approachable assortment are tenets of how we champion diversity at Ulta Beauty,” continued Dillon. “We have mapped these commitments to impact every facet of our work. We look forward to sharing more as we continue on this journey with steadfast commitment from our teams and our newly established advisor Tracee Ellis Ross, who brings passion, experience and perspective to this important work.”

In her role as Diversity and Inclusion Advisor, Ross, a beauty entrepreneur, activist and actor, will provide counsel and insight, and drive accountability to Ulta Beauty with a specific focus on BIPOC brand development, diverse leadership development and supplier diversity. She will join internal Executive D&I Council Summits quarterly. The executive council is chaired by Dillon and brings together Ulta Beauty’s executive team to holistically review D&I progress, gaps and opportunities.

With a formalized internal governance in place across the enterprise, Ulta Beauty is committed to progress and will share updates as it continues to build upon its diversity and inclusion efforts.

About Ulta Beauty

At Ulta Beauty (NASDAQ: ULTA), the possibilities are beautiful. Ulta Beauty is the largest U.S. beauty retailer and the premier beauty destination for cosmetics, fragrance, skin care products, hair care products and salon services. In 1990, the Company reinvented the beauty retail experience by offering a new way to shop for beauty – bringing together all things beauty, all in one place. Today, Ulta Beauty operates more than 1,250 retail stores across 50 states and also distributes its products through its website, which includes a collection of tips, tutorials, and social content. For more information, visit www.ulta.com.

Ulta Beauty was recently added to the Bloomberg Gender Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. More information about Ulta Beauty’s corporate responsibility efforts can be found at www.ir.ultabeauty.com/Corporate-Responsibility.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005283/en/

Ulta Beauty Media Contact:

Eileen Ziesemer

Vice President, Public Relations

[email protected]

(708) 305-4479

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Fashion Luxury Cosmetics Retail Specialty

MEDIA:

Logo

Magnite Introduces Open Beta of New CTV & OTT Solution Named Unified Decisioning

Empowers CTV and OTT Publishers to Maximize Yield by Unifying Direct and Programmatic Demand

Global Publishers Among Users, Including Australia’s Seven West Media

NEW YORK & LOS ANGELES–(BUSINESS WIRE)–
Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising platform, today launched the open beta of Unified Decisioning, a solution that empowers CTV and OTT publishers to maximize yield by removing the need to manage direct sold and programmatic demand channels independently and allowing them to compete side by side. As the TV industry transitions away from manual processes and splintered transaction channels, Magnite’s solution brings the same control and flexibility that have long existed in the direct world to the realm of programmatic media.

Unified Decisioning gives publishers the tools and controls to define when and how direct sold and programmatic demand should compete. The solution works alongside all major ad servers to ensure that the optimal ad set is chosen that will take into consideration both direct and programmatic deal priority and yield while ensuring publisher’s business rules, including frequency capping and competitive separation, are enforced.

“We’ve designed and built Unified Decisioning to address the barriers between unifying direct sold and programmatic demand with the specific needs of CTV publishers in mind,” commented Paige Bilins, Vice President of Video Product Management at Magnite. “Publishers are eager to tap into the efficiencies that programmatic provides without relinquishing the control they are used to when selling directly to buyers. Unified Decisioning enables them to do both and we’re excited to bring these capabilities to leading CTV publishers.”

“The early results we’ve seen using Magnite’s Unified Decisioning to ensure optimal delivery of direct and programmatic demand have been promising,” said Luke Smith, Head of Programmatic Sales at Seven West Media. “We’ve set ourselves the goal of improving the value for advertisers and audiences and are so far pleased with the ability to apply complex business rules and see the valuable data and analytics in real-time. Magnite has been a long-trusted partner and has a history of delivering innovative solutions to support our continued growth. We look forward to continuing that partnership with the use of the Unified Decisioning across our BVOD business.”

Unified Decisioning brings benefits to the demand side as well. Programmatic buyers and brands will have greater insight into available inventory and have an equal opportunity to compete for premium video content. As an independent solution, Unified Decisioning is ad server agnostic and has no conflicting demand agenda.

“As connected TV becomes a more significant part of advertisers’ media plans, we applaud Magnite for instituting Unified Decisioning that unlocks more premium video inventory and deeper insights into available supply,” said Jon Tabak, General Manager, Strategic Partnerships, The Trade Desk. “The industry continues to grow together to make the TV marketplace more transparent and efficient for buyers and sellers amidst the generational shift of consumers from linear TV to CTV.”

Magnite clients interested in learning more about the Unified Decisioning Open Beta can contact their Account Team. Prospective users can reach us at magnite.com/contact-us/.

About Magnite

We’re Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising platform. Publishers use our technology to monetize their content across all screens and formats—including desktop, mobile, audio and CTV. And the world’s leading agencies and brands trust our platform to access brand-safe, high-quality ad inventory and execute billions of advertising transactions each month. Anchored in sunny Los Angeles, bustling New York City, historic London, and down under in Sydney, Magnite has offices across North America, EMEA, LATAM and APAC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005138/en/

For more information, quotes or interview requests, contact:

Charlstie Veith: [email protected] / + 1 516 300 3569

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS: Data Management Advertising Communications Technology Other Technology Publishing

MEDIA:

Posted on February 2, 2021 8:03 am

Zebra Technologies’ Jeff Barteld Recognized as a 2021 CRN Channel Chief

Zebra Technologies’ Jeff Barteld Recognized as a 2021 CRN Channel Chief

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front line of business with solutions and partners that deliver a performance edge, today announced CRN®, a brand of The Channel Company, has named Jeff Barteld, Senior Director of Global Channel Strategy and Programs to its 2021 list of Channel Chiefs. Released annually, the prestigious CRN® Channel Chiefs list recognizes leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth.

The 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs and partnerships. All honorees are selected by CRN’s editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates.

Barteld is responsible for channel strategy and programs and last year, he and his team led the creation of a framework and process for new channel development to more quickly build programs outside of Zebra’s core business. In response to COVID-19, Barteld and his team also updated PartnerConnect program guidelines to support partners and help them focus on their business, employees and customers.

“CRN’s 2021 Channel Chiefs list includes the industry’s biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market,” said Blaine Raddon, CEO of The Channel Company. “The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success.”

CRN’s 2021 Channel Chiefs list will be featured in the February 2021 issue of CRN^® Magazine and online at www.CRN.com/ChannelChiefs.

ABOUT ZEBRATECHNOLOGIES

Zebra (NASDAQ: ZBRA) empowers the front line in retail/ecommerce, manufacturing, transportation and logistics, healthcare, public sector and other industries to achieve a performance edge. With more than 10,000 partners across 100 countries, Zebra delivers industry-tailored, end-to-end solutions to enable every asset and worker to be visible, connected and fully optimized. The company’s market-leading solutions elevate the shopping experience, track and manage inventory as well as improve supply chain efficiency and patient care. In 2020, Zebra made Forbes Global 2000 list for the second consecutive year and was listed among Fast Company’s Best Companies for Innovators. For more information, visit www.zebra.com or sign up for news alerts. Participate in Zebra’s Your Edge blog, follow the company on LinkedIn, Twitter and Facebook, and check out our Story Hub: Zebra Perspectives.

About The Channel Company

The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace. www.thechannelcompany.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005015/en/

Media Contacts:

Emily Alfano

Zebra Technologies

Phone: +1-262-960-6108

[email protected]

Jennifer Hogan

The Channel Company

[email protected]

Industry Analyst Contact:

Kasia Fahmy

Zebra Technologies

+1-224-306-8654

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Other Manufacturing Technology Transport Manufacturing Software Logistics/Supply Chain Management Retail Data Management Online Retail

MEDIA:

Logo

VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine

– FDA sets a target action date of November 30, 2021

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the U.S. Food and Drug Administration (FDA) has accepted its filing of the Biologics License Application (BLA) for the Company’s 3-antigen prophylactic hepatitis B vaccine candidate for the prevention of infection caused by all known subtypes of the hepatitis B virus (HBV) in adults. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2021.

“The FDA acceptance of our BLA represents a significant milestone for VBI, but more importantly for the effort to provide broad access to this vaccine, which we believe has the potential to be a meaningful intervention for adults in the fight against hepatitis B,” said Jeff Baxter, President & CEO. “Progress in preventing HBV infection has stalled, and the 11 percent increase in U.S. acute cases from 2014 to 2018 highlights the need for renewed focus, innovation, and action in the space. We are committed to working with the FDA throughout their review process over the course of this year as we work to address this serious, but preventable, public health threat.”

Additionally, in the filing notification letter, the FDA communicated that it is not currently planning to hold an advisory committee meeting to discuss the application.

The BLA is supported by data from the two pivotal, randomized, double-blind, controlled Phase 3 studies – PROTECT and CONSTANT – in addition to other relevant data. The studies were designed to assess the efficacy and safety of VBI’s 3-antigen HBV vaccine compared with Engerix-B®, as well as the lot-to-lot manufacturing consistency of VBI’s vaccine.

About Hepatitis B

Hepatitis B is one of the world’s most significant infectious disease threats with more than 290 million people infected globally. HBV infection is the leading cause of liver disease and, with current treatments, it is very difficult to cure, with many patients going on to develop liver cancers. An estimated 780,000 people die each year from complications of chronic HBV such as liver decompensation and hepatocellular carcinoma.

About VBI’s 3-Antigen Hepatitis B Vaccine

VBI’s vaccine candidate is the only 3-antigen hepatitis B vaccine, comprised of the S, pre-S1, and pre-S2 surface antigens of the hepatitis B virus, and is approved for use and commercially-available in Israel. In December 2017, VBI initiated patient dosing in a global Phase 3 clinical program that consisted of two concurrent pivotal studies: PROTECT, a safety and immunogenicity study, and CONSTANT, a lot-to-lot consistency study. Data from both the PROTECT study and the CONSTANT study, which were announced in June 2019 and January 2020, respectively, comprise the basis for the regulatory submissions in the U.S., Europe, and Canada. This vaccine is sold under the name Sci-B-Vac® in Israel.

To learn more about VBI’s 3-Antigen Hepatitis B vaccine visit: https://www.vbivaccines.com/sci-b-vac/

About VBI Vaccines Inc.

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI is advancing the prevention and treatment of hepatitis B, with: (1) the only 3-antigen hepatitis B vaccine, which is approved for use and commercially available in Israel under the name Sci-B-Vac® and completed its Phase 3 program in the U.S., Europe, and Canada in 2020; and (2) an immunotherapeutic in development for a functional cure for chronic hepatitis B. VBI’s enveloped virus-like particle (eVLP) platform technology enables development of eVLPs that closely mimic the target virus to elicit a potent immune response. VBI’s lead eVLP programs include a vaccine immunotherapeutic candidate targeting glioblastoma (GBM), a prophylactic cytomegalovirus (CMV) vaccine candidate, and a prophylactic coronavirus vaccine program. VBI is headquartered in Cambridge, MA, with research operations in Ottawa, Canada, and research and manufacturing facilities in Rehovot, Israel.

Website Home: http://www.vbivaccines.com/

News and Insights: http://www.vbivaccines.com/wire/

Investors: http://www.vbivaccines.com/investors/

Cautionary Statement on Forward-looking Information

Certain statements in this press release that are forward-looking and not statements of historical fact are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are forward-looking information within the meaning of Canadian securities laws (collectively, “forward-looking statements”). The Company cautions that such statements involve risks and uncertainties that may materially affect the Company’s results of operations. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, the impact of general economic, industry or political conditions in the United States or internationally; the impact of the ongoing COVID-19 pandemic on our clinical studies, manufacturing, business plan, and the global economy; the ability to establish that potential products are efficacious or safe in preclinical or clinical trials; unanticipated delays in both the commencement and completion of our planned clinical trials; the ability to establish or maintain collaborations on the development of therapeutic candidates; the ability to obtain appropriate or necessary governmental approvals to market potential products; the ability to obtain future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms; the Company’s ability to manufacture product candidates on a commercial scale or in collaborations with third parties; changes in the size and nature of competitors; the ability to retain key executives and scientists; and the ability to secure and enforce legal rights related to the Company’s products. A discussion of these and other factors, including risks and uncertainties with respect to the Company, is set forth in the Company’s filings with the SEC and the Canadian securities authorities, including its Annual Report on Form 10-K filed with the SEC on March 5, 2020, and filed with the Canadian security authorities at sedar.com on March 5, 2020, as may be supplemented or amended by the Company’s Quarterly Reports on Form 10-Q. Given these risks, uncertainties and factors, you are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. All such forward-looking statements made herein are based on our current expectations and we undertake no duty or obligation to update or revise any forward-looking statements for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005180/en/

Nicole Anderson

Director, Corporate Communications & IR

Phone: (617) 830-3031 x124

Email: [email protected]

KEYWORDS: Massachusetts United States North America Canada

INDUSTRY KEYWORDS: Research Infectious Diseases FDA Clinical Trials Other Health Biotechnology Pharmaceutical Health Science Oncology

MEDIA:

Logo